FOCUS ON US: Support for Sexual and Gender Minority Cancer Patients and Caregivers
This study is testing a support program called FOCUS ON US for cancer patients and their caregivers who identify as sexual and/or gender minorities (SGM). The program has 5 sessions covering areas like family involvement, outlook, coping, reducing uncertainty, and managing symptoms. You may be able to join if you are an adult (18-100 years old) who has been diagnosed with cancer in the last two years, or had a recurrence, and you or your caregiver identify as SGM. The study aims to see if the FOCUS ON US program is practical and well-received, and to explore its potential benefits. We are looking for 160 participants in total.
- Study design
- This is an interventional study where 160 participants (80 SGM cancer patients and 80 caregivers) will be randomly assigned to either receive the FOCUS ON US program or be in a waitlist control group.
- What's involved
- The FOCUS ON US intervention includes 5 sessions. The study will measure feasibility and acceptability at 3 months after you are assigned to a group.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study measures outcomes at 3 months after randomization.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
FOCUS ON US: Adapting the FOCUS Program for Sexual and Gender Minority (SGM) Cancer Patients and Caregivers
At a glance
Conditions
Where it's being run
2 sites across 2 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Feasibility of Intervention3 months after randomization
To assess retention feasibility, we will consider the intervention feasible if ≥75% of participants attend the majority of FOCUS On Us sessions (3 out of 5, 2 of which are longer content sessions), and ≥75% complete post-intervention and 3-month follow-up assessments. The feasibility estimates will be reported as a percentage +/- a 95% confidence interval.
- Acceptability3 months after randomization
We will consider the intervention acceptable if 80% of participants are highly satisfied with FOCUS On Us on our satisfaction questionnaire (average rating ≥4 out of a maximum of 5).